| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,863 |
15,431 |
$2.45M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,438 |
5,809 |
$1.04M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
5,470 |
5,003 |
$734K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,061 |
1,780 |
$638K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,824 |
1,638 |
$577K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,069 |
1,890 |
$279K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,204 |
1,442 |
$160K |
| 80053 |
Comprehensive metabolic panel |
11,471 |
10,337 |
$152K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
621 |
610 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
522 |
485 |
$39K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
109 |
100 |
$35K |
| 64721 |
|
32 |
29 |
$32K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
360 |
343 |
$30K |
| 70450 |
Computed tomography, head or brain; without contrast material |
169 |
147 |
$30K |
| 83605 |
|
1,426 |
1,158 |
$21K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,969 |
577 |
$15K |
| 84484 |
|
1,318 |
872 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,320 |
1,166 |
$14K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
910 |
521 |
$13K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
44 |
38 |
$9K |
| 76830 |
Ultrasound, transvaginal |
55 |
40 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
40 |
40 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,812 |
2,501 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
16 |
15 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
75 |
52 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
7,077 |
6,364 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
27 |
26 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
49 |
38 |
$3K |
| G0378 |
Hospital observation service, per hour |
26 |
12 |
$3K |
| 87400 |
|
82 |
31 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
14 |
13 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,853 |
2,985 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,115 |
4,140 |
$1K |
| 80047 |
|
44 |
40 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,105 |
15,241 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
625 |
544 |
$961.93 |
| 87420 |
|
14 |
12 |
$904.86 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
350 |
307 |
$883.85 |
| 81001 |
|
2,160 |
1,991 |
$671.70 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,806 |
1,710 |
$533.85 |
| 71045 |
Radiologic examination, chest; single view |
1,348 |
1,234 |
$361.26 |
| 80076 |
|
16 |
13 |
$352.41 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,741 |
2,557 |
$309.14 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
18 |
12 |
$235.48 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
651 |
453 |
$226.96 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
114 |
108 |
$173.57 |
| 97161 |
|
14 |
12 |
$151.95 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
291 |
280 |
$140.38 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
711 |
644 |
$128.57 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
780 |
707 |
$90.00 |
| 81003 |
|
232 |
216 |
$88.04 |
| J2704 |
Injection, propofol, 10 mg |
2,583 |
1,683 |
$79.87 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
187 |
174 |
$63.91 |
| 83690 |
|
813 |
747 |
$42.85 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,637 |
1,432 |
$42.25 |
| 81025 |
|
75 |
67 |
$28.68 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,465 |
1,136 |
$28.46 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
113 |
89 |
$28.02 |
| 82077 |
|
78 |
65 |
$16.23 |
| 85610 |
|
12 |
12 |
$2.58 |
| J3490 |
Unclassified drugs |
14,612 |
7,453 |
$1.77 |
| 85014 |
|
29 |
24 |
$0.00 |
| 0753T |
|
17 |
12 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
63 |
26 |
$0.00 |
| 82565 |
|
68 |
40 |
$0.00 |
| 0752T |
|
13 |
12 |
$0.00 |
| 82947 |
|
67 |
40 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
14 |
14 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
30 |
29 |
$0.00 |
| 84540 |
|
86 |
54 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
921 |
845 |
$0.00 |
| 85018 |
|
30 |
25 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,481 |
1,061 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
714 |
644 |
$0.00 |
| 80051 |
|
68 |
40 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
56 |
51 |
$0.00 |
| 88304 |
|
13 |
12 |
$0.00 |
| 82330 |
|
86 |
54 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
48 |
40 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
57 |
53 |
$0.00 |
| 83735 |
|
19 |
15 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
19 |
17 |
$0.00 |